I don't get it. Drug sales are so minimal compared to the overall healthcare sector. Something like only 10%. I get certain areas have nefarious actions but that is seen everywhere. The should focus on the cost of education first. Insanely inflated and a bubble that needs to pop.
They contract out to 3rd parties for their research. That is considered a general expense. The R&D line item would be for internal R&D.
A leader in the class action would have stepped forward already.